![V. Lokesh Battula: Our findings on resistance to Fluorothymidine 3 inhibitors in Acute Myeloid Leukemia are now published in the Leukemia Journal](https://oncodaily.com/pub/uploads/2023/11/IMG_4547-e1701369218961.png)
Photo from V. Lokesh Battula/LinkedIn
Dec 1, 2023, 19:13
V. Lokesh Battula: Our findings on resistance to Fluorothymidine 3 inhibitors in Acute Myeloid Leukemia are now published in the Leukemia Journal
V. Lokesh Battula, Associate Professor at MD Anderson Cancer Center, shared on LinkedIn:
“Happy to report that our findings on resistance to FLT3 inhibitors in AML are now published in the Leukemia Journal. In this report, we have reported ACVR1 as a novel resistance factor for FLT3 inhibitors in AML and introduced a novel FLT3-ACVR1 dual inhibitor (TP-0184) as a single agent to target both FLT3 and its resistance factor in AML!”
Read the article here.
Source: V. Lokesh Battula/LinkedIn